Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Phrenic Neuropathy Water Immersion Dyspnea: Clinical Findings and Need for Patient Counseling
Neuromuscular and Clinical Neurophysiology (EMG)
P13 - Poster Session 13 (5:30 PM-6:30 PM)
1-012

To investigate among phrenic neuropathy patients: (1) occurrences of water immersion induced dyspnea, (2) clinical, electrophysiological, sonographic, and pulmonary function test abnormalities, and (3) physician documented counseling regarding risks of water related activities.

Water immersion results in upward buoyancy effect on the diaphragm and increased chest wall pressure thereby reducing lung capacity as much as 50% in patients with diaphragmatic weakness. Despite this known effect, the potential risks of submersion and water-related activities are often overlooked by patients and clinicians.

We reviewed the medical charts of phrenic neuropathy patients diagnosed from January 1 2000 to December 31 2018 and compared clinico-demographic characteristics and diagnostic test results between those with documented vs. non-documented dyspnea in water. 

Of 535 phrenic neuropathy cases, dyspnea with water activities was documented in 4% (22/535). The majority were men (81.9%), mean age 55 years (range 31-79) with isolated phrenic neuritis or neuralgic amyotrophy syndrome (77.3%). They had right-sided (45.5%) or bilateral (54.5%) phrenic involvement. Near-fatal drowning occurred in 18.2% (4/22) with persons needing assistance to be rescued following diving into water. Dyspnea with water immersion was the only symptom in 4.5% (1/22), and the presenting respiratory symptom in 36.4% (8/22). None had isolated left phrenic involvement. A range of electrophysiological, sonographic and pulmonary function test abnormalities including mild abnormalities were seen and not found to be significantly different to patients in whom water induced dyspnea was not recorded.

Respiratory distress with water immersion activities is a serious complication of phrenic neuropathies. Physician documented counseling is lacking. Isolated phrenic neuritis, neuralgic amyotrophy, right sided and bilateral phrenic involvement are most commonly implicated, but the range of severity and testing abnormalities suggests all neuralgic amyotrophy and phrenic neuropathy patients should be warned especially about diving into water.

Authors/Disclosures
Rocio Vazquez Do Campo, MD (University of Alabama at Birmingham)
PRESENTER
Dr. Vazquez Do Campo has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with US Department of Health, vaccine compensation program.
Shahar Shelly, MD (Rambam Medical Center) Dr. Shelly has or had stock in Remepy.
Pritikanta Paul, MD (University of California, San Francisco) The institution of Dr. Paul has received research support from ZS Associates.
Hongyan Bi No disclosure on file
Andrea Boon, MD (Mayo Clinic) Dr. Boon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HPE cosmetics .
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Robert Vassallo Robert Vassallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Robert Vassallo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Rion. Robert Vassallo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Robert Vassallo has stock in Rion LLC. The institution of Robert Vassallo has received research support from NIH. The institution of Robert Vassallo has received research support from DOD. Robert Vassallo has received intellectual property interests from a discovery or technology relating to health care.
Christopher J. Klein, MD, FÂé¶¹´«Ã½Ó³»­ (Mayo Clinic) Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.